Flu shots aren't as good as we'd really like them to be. Pfizer and its competitor, Moderna, have here is that they can compress the production timeline for a shot. Wall Street doesn't feel too bullish about Pfizer right now.
Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek."
Hosted by Carol Massar and Tim Stenovec
Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 106.1 FM Boston, Bloomberg 960 AM San Francisco, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 119, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio.
You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News.
Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BW
See omnystudio.com/listener for privacy information.